By: Matthew Herper, Elaine Chen
Panel's deliberations are key for company — and could signal the agency's broader posture
Senior Writer, Medicine, and Editorial Director, Events
Matthew Herper is a senior writer at STAT, where he covers medicine and oversees the editorial portion of STAT’s events, including its industry-leading Summits. With two decades of experience, he explores themes of medical innovation, biotechnology, and healthcare technology, examining both the promises and challenges within the field. He has been featured in RealClearHealth, STAT News, RamaOnHealthcare, STAT, and The Boston Globe.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Matthew Herper's coverage primarily focuses on the healthcare and pharmaceutical sectors, with an emphasis on data-driven insights and industry announcements. His articles frequently cite data, incorporate press releases, and feature private sector announcements.
Given his extensive use of data in reporting, he may be particularly interested in sources who can provide statistical analysis or empirical evidence related to developments in pharmaceuticals, medical research, cancer treatment, gene editing, or drug development.
He does not appear to have a specific geographic focus but provides comprehensive coverage of global trends within the healthcare and pharmaceutical industries. When reaching out to him with pitches or expert commentary offers it should align with these thematic areas for higher chances of engagement.
This information evolves through artificial intelligence and human feedback. Improve this profile .